Breaking News

Friday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
ADXS Advaxis $0.81 0.0168 (2.12%) 10:38 09/14/18 09/14 10:38 09/14/18 10:38 Hot Stocks	CVI Investments reports 6% stake in Advaxis » CVI Investments discloses… CVI Investments discloses a 6.0% stake in Advaxis, which represents over 4.16M shares. The filing is for a passive stake and does not allow for activism. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Oct

Thursday
URGN UroGen Pharma $44.69 0.39 (0.88%) 16:33 09/13/18 09/13 16:33 09/13/18 16:33 Initiation	UroGen Pharma initiated at Stifel » UroGen Pharma initiated… UroGen Pharma initiated with a Buy at Stifel. Stifel analyst Derek Archila initiated UroGen Pharma with a Buy rating and a $70 price target. Archila noted that the company has a late-stage asset that is largely de-risked with an attractive, niche commercial opportunity, and also has an emerging pipeline and validated platform. The analyst added that investors are under appreciating the opportunity for MitoGel in UTUC, and believes the stock has room to run. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

Wednesday
ADXS Advaxis $0.85 -0.1135 (-11.74%) 07:07 09/12/18 09/12 07:07 09/12/18 07:07 Recommendations	Advaxis analyst commentary at H.C. Wainwright » Advaxis price target… Advaxis price target lowered to $2 from $3 at H.C. Wainwright. H.C. Wainwright analyst Swayampakula Ramakanth lowered his price target for Advaxis to $2 following the company's Q3 results but keeps a Buy rating on the shares. The analyst believes the company has sufficient cash to fund its operations into the second half of 2019, and his new price target reflects expected dilution from the $20M equity raise on September 11. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Oct

Over a week ago
CDMO Avid Bioservices $7.18 0.06 (0.84%) , CASY Casey's General Stores $116.71 1.71 (1.49%) … 18:45 09/10/18 09/10 18:45 09/10/18 18:45 Hot Stocks	Fly Intel: After Hours Movers » UP AFTER EARNINGS: Avid… UP AFTER EARNINGS: Avid Bioservices (CDMO) up 17.0%... Casey's General Stores (CASY) up 4.7%... Adaxis (ADXS) up 2.5%. ALSO HIGHER: SIGA Technologies (SIGA) up 20.6% after being awarded TPOXX contract...Nutanix (NTNX) up 4.2% after disclosing Defense Department contract...Trevena (TRVN) up 3.5% after announcing FDA meeting to discuss oliceridine injection. DOWN AFTER EARNINGS: Limoneira (LMNR) down 15.9%... Sonos (SONO) down 12.9%... Matrix Service (MTRX) down 11.0%. ALSO LOWER: NN (NNBR) down 7.1% after equity offering... Endocyte (ECYT) down 4.7% after equity offering... Phillips 66 (PSX) down 2.2% after Berkshire disclosed lower stake... Insulet (PODD) down 1.0% after naming new CEO. CDMO Avid Bioservices $7.18 0.06 (0.84%) CASY Casey's General Stores $116.71 1.71 (1.49%) ADXS Advaxis $0.97 -0.0385 (-3.83%) SIGA Siga Technologies $7.05 -0.19 (-2.62%) NTNX Nutanix $51.80 0.49 (0.95%) TRVN Trevena $1.70 0.02 (1.19%) LMNR Limoneira $33.15 0.83 (2.57%) SONO Sonos $21.17 2.47 (13.21%) MTRX Matrix Service $21.20 0.25 (1.19%) NNBR NN, Inc. $19.85 (0.00%) ECYT Endocyte $18.89 1.96 (11.58%) PSX Phillips 66 $113.96 -0.275 (-0.24%) PODD Insulet $105.70 2.08 (2.01%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	10 Sep 10 Sep 10 Sep 10 Sep 11 Sep 12 Sep 12 Sep 13 Sep 13 Sep 17 Sep 17 Sep 20 Sep 25 Sep 26 Sep 22 Oct 06 Nov 12 Sep 14 Sep
ADXS Advaxis $0.97 -0.0385 (-3.83%) 16:31 09/10/18 09/10 16:31 09/10/18 16:31 Earnings	Advaxis reports Q3 EPS (27c), consensus (25c) » Reports Q3 revenue… Reports Q3 revenue $1.13M, consensus $1.85M. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Oct

Over a week ago

CDMO

Avid Bioservices

$7.18: 0.06 (0.84%)

, CASY

Casey's General Stores

$116.71: 1.71 (1.49%)

… 18:45

09/10/18

09/10

18:45

09/10/18

18:45

Hot Stocks

Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Avid…

CDMO

Avid Bioservices

$7.18: 0.06 (0.84%)

CASY

Casey's General Stores

$116.71: 1.71 (1.49%)

ADXS

Advaxis

$0.97: -0.0385 (-3.83%)

SIGA

Siga Technologies

$7.05: -0.19 (-2.62%)

NTNX

Nutanix

$51.80: 0.49 (0.95%)

TRVN

Trevena

$1.70: 0.02 (1.19%)

LMNR

Limoneira

$33.15: 0.83 (2.57%)

SONO

Sonos

$21.17: 2.47 (13.21%)

MTRX

Matrix Service

$21.20: 0.25 (1.19%)

NNBR

NN, Inc.

$19.85: (0.00%)

ECYT

Endocyte

$18.89: 1.96 (11.58%)

PSX

Phillips 66

$113.96: -0.275 (-0.24%)

PODD

Insulet

$105.70: 2.08 (2.01%)

03/08/13: Wedge Partners

03/08/13: Credit Suisse

03/06/13: Citigroup

03/06/13: Barclays

See Street Research during your Free Trial

10
Sep
10
Sep
10
Sep
10
Sep
11
Sep
12
Sep
12
Sep
13
Sep
13
Sep
17
Sep
17
Sep
20
Sep
25
Sep
26
Sep
22
Oct
06
Nov

12
Sep
14
Sep

ADXS

Advaxis

$0.97: -0.0385 (-3.83%)

16:31

09/10/18

09/10

16:31

09/10/18

16:31

Earnings

Advaxis reports Q3 EPS (27c), consensus (25c) »

Reports Q3 revenue…

03/08/13: Wedge Partners

03/08/13: Credit Suisse

03/06/13: Citigroup

03/06/13: Barclays

See Street Research during your Free Trial

22
Oct

SRRA Sierra Oncology $1.84 -0.06 (-3.16%) 16:12 09/07/18 09/07 16:12 09/07/18 16:12 Hot Stocks	Breaking Hot Stocks news story on Sierra Oncology » Broadfin Capital reports… Broadfin Capital reports 5.5% passive stake in Sierra Oncology 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ADXS Advaxis $1.41 -0.1 (-6.62%) 09:38 09/07/18 09/07 09:38 09/07/18 09:38 Syndicate	Advaxis 16.667M share Spot Secondary priced at $1.20 » Cantor Fitzgerald and… Cantor Fitzgerald and Oppenheimer acted as joint book running managers for the offering. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Oct 07 Sep
INFI Infinity Pharmaceuticals $2.48 0.04 (1.64%) , NTRP Neurotrope $9.40 0.39 (4.33%) … 07:33 09/07/18 09/07 07:33 09/07/18 07:33 Conference/Events	BioCentury to hold a conference » 25th Annual NewsMakers in… 25th Annual NewsMakers in the Biotech Industry will be held in New York on September 7. INFI Infinity Pharmaceuticals $2.48 0.04 (1.64%) NTRP Neurotrope $9.40 0.39 (4.33%) TNXP Tonix Pharmaceuticals $1.02 -0.02 (-1.92%) ARCT Arcturus Therapeutics $7.91 -0.06 (-0.75%) OVID Ovid Therapeutics $6.09 -0.23 (-3.64%) OBSV ObsEva $13.57 0.02 (0.15%) EIGR Eiger BioPharmaceuticals $12.50 -0.3 (-2.34%) BSTC BioSpecifics $54.33 -0.21 (-0.39%) TPIV TapImmune $9.18 -0.47 (-4.87%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	07 Sep
ADXS Advaxis $1.41 -0.1 (-6.62%) 17:11 09/06/18 09/06 17:11 09/06/18 17:11 Syndicate	Advaxis announces common stock offering » Advaxis announced that it… Advaxis announced that it intends to offer and sell in an underwritten public offering shares of its common stock, with each share of common stock to be sold together in a fixed combination with a warrant to purchase common stock. Cantor Fitzgerald & Co. and Oppenheimer & Co. are acting as joint book-running managers for the offering. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Oct
BYSI BeyondSpring $21.60 -0.35 (-1.59%) 07:07 09/06/18 09/06 07:07 09/06/18 07:07 Hot Stocks	BeyondSpring to present Plinabulin data at IASLC » BeyondSpring will present… BeyondSpring will present clinical trial data on its lead asset, Plinabulin, during a poster presentation at the International Association for the Study of Lung Cancer, or IASLC. The data demonstrated that Plinabulin, a novel, non-G-CSF small molecule in development for the prevention of chemotherapy-induced neutropenia and for the treatment of non-small cell lung cancer, or NSCLC, mitigated both docetaxel CIN and thrombocytopenia in patients with advanced NSCLC. Thrombocytopenia, a frequent side effect of chemotherapy, is a lowering of platelet counts that, when severe, leads to bleeding and anemia and can require transfusion with platelets. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

08:46	Madrigal falls after Viking's fatty liver disease study hits primary goal»
18:50	Fly Intel: After Hours Movers»
16:20	Fly Intel: Wall Street's top stories for Monday»
14:31	Nutanix slips as Google Cloud reportedly tests devices for private data centers»
12:43	Fly Intel: What to watch for in Oracle's earnings report»

ARCE	Arco Platform - ARCE
FTCH	Farfetch - FTCH
	Code Commerce 2018
EMLAF ...	Scotiabank Back to School Conference
	Internet Bus Tour
	China Ag Trip
AMRX ...	Generics/Biosimilars Investor Tour
WST ...	Healthcare Conference 2018
	U.S. All Stars Conference
AER ...	Aircraft Leasing Investor Day

Get Full Fly Access